The FDA sent 30 warning letters to GLP-1 compounders on February 20, 2026, flagging violations including claims of "same active ingredients" as brand-name drugs, language implying therapeutic equivalence, and statements implying FDA approval of compounded products
After the adjusted analysis, p -values 0.05)
This is a research-focused reference, not a prescribing guide
For most GLP-1 users without identified deficiencies, a high-quality multivitamin and mineral supplement designed to provide approximately 100% of the recommended daily amounts may be appropriate
Glutathione is a tripeptide composed of three amino acids: glutamine, glycine, and cysteine
That means COAs, third-party testing, community reviews, and systematic vendor evaluation become your quality assurance system